No Clinically Significant Interaction Between Hiprex and Nitrofurantoin
There is no documented drug interaction between Hiprex (methenamine hippurate) and nitrofurantoin, and these medications can be used together when clinically indicated. In fact, recent high-quality evidence demonstrates they are often compared as alternative prophylactic strategies for recurrent UTIs, and patients may transition between them without concern for drug-drug interactions 1, 2.
Key Evidence Supporting Safety
The FDA label for Hiprex explicitly lists only one drug contraindication: sulfonamides (not nitrofurantoin), which can form insoluble precipitates with formaldehyde in urine 3. Nitrofurantoin is conspicuously absent from this contraindication list.
Multiple recent guidelines and clinical trials directly support the compatibility of these agents:
The 2026 AUA/CUA/SUFU guideline describes a landmark non-inferiority trial where patients received either methenamine hippurate 1g twice daily OR nitrofurantoin 50/100mg daily as prophylaxis, with the study design explicitly allowing crossover between treatment arms 1. This crossover provision would be contraindicated if there were safety concerns about combining these medications.
The ALTAR trial (2022), a large pragmatic RCT with 240 women, similarly compared methenamine hippurate directly against nitrofurantoin prophylaxis and permitted treatment crossover, demonstrating no safety signals when patients switched between agents 2.
Clinical Context
These medications work through entirely different mechanisms:
- Methenamine hippurate converts to formaldehyde in acidic urine, providing non-antibiotic antiseptic activity
- Nitrofurantoin is a true antibiotic with distinct pharmacology
Both are recommended as first-line options for UTI prophylaxis in current European and North American guidelines 4, 1. The 2026 EAU guidelines list nitrofurantoin as a strong first-line recommendation for acute cystitis treatment 4, while methenamine receives conditional recommendation for prophylaxis 1.
Important Caveat
While these drugs don't interact with each other, be aware that methenamine should not be combined with sulfonamide antibiotics (trimethoprim-sulfamethoxazole, sulfisoxazole, etc.) due to precipitation risk 3. This is the only documented drug interaction for methenamine hippurate.
Bottom line: Continue both medications if clinically appropriate. The patient can safely take Hiprex and nitrofurantoin together or sequentially without dose adjustment or special monitoring beyond standard care for each individual agent.